chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Electrocardiogram ST segment elevation, Fatigue, Gait disturbance, Immunisation reaction, Myopericarditis
Clinical narrative: This case was received on 02 February 2009 via a QScan search on the VAERS database, under reference number 332168. A 24-year-old male patient, who was previously healthy, received ACAM2000 (lot number not reported) on 24 September 2008. On 03 October 2008, nine days post vaccination, the patient developed pleuritic and substernal chest pain (6-7 out of 10), fever, but no dyspnea. On 05 October 2008, the symptoms persisted and the patient went to a health facility. On exam, the patient was afebrile with stable vital signs and O2 saturation on room air. His temperature was 98.6, pulse 86, B/P 99/63, respirations 16. Physical exam was essentially unremarkable. His primary inoculation site was healing over as anticipated. He had some costochondral tenderness. No signs and symptoms of reduced LV function by physical exam. He received INDOCIN 50 mg, which nearly alleviated his chest pain, and he was doing well since. On 08 October 2008, the patient had new onset of chest pain which was associated with occasional mild dyspnea and dizziness, cough, night sweats, fatigue, weight loss, chronic low back pain, weakness with difficulty walking, and diffuse tenderness to palpitation over most of sternum. The impression was myopericarditis, secondary to immune response to smallpox immunization. Laboratory and diagnostic test results included the following: Serum qualitative Troponin I was positive; Serum CKMB 27 (just above intermediate range upper limit of normal); essentially normal electrolytes and BUN/Cr; EKG: normal sinus rhythm and one to two millimeter ST segment elevations in II, III. The patient was reported to have been hospitalized on unspecified dates. The patient's outcome was recovered. NOTE: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Night sweats, Pleuritic pain, Pyrexia, Tenderness, Troponin I increased
Clinical narrative: This case was received on 02 February 2009 via a QScan search on the VAERS database, under reference number 332168. A 24-year-old male patient, who was previously healthy, received ACAM2000 (lot number not reported) on 24 September 2008. On 03 October 2008, nine days post vaccination, the patient developed pleuritic and substernal chest pain (6-7 out of 10), fever, but no dyspnea. On 05 October 2008, the symptoms persisted and the patient went to a health facility. On exam, the patient was afebrile with stable vital signs and O2 saturation on room air. His temperature was 98.6, pulse 86, B/P 99/63, respirations 16. Physical exam was essentially unremarkable. His primary inoculation site was healing over as anticipated. He had some costochondral tenderness. No signs and symptoms of reduced LV function by physical exam. He received INDOCIN 50 mg, which nearly alleviated his chest pain, and he was doing well since. On 08 October 2008, the patient had new onset of chest pain which was associated with occasional mild dyspnea and dizziness, cough, night sweats, fatigue, weight loss, chronic low back pain, weakness with difficulty walking, and diffuse tenderness to palpitation over most of sternum. The impression was myopericarditis, secondary to immune response to smallpox immunization. Laboratory and diagnostic test results included the following: Serum qualitative Troponin I was positive; Serum CKMB 27 (just above intermediate range upper limit of normal); essentially normal electrolytes and BUN/Cr; EKG: normal sinus rhythm and one to two millimeter ST segment elevations in II, III. The patient was reported to have been hospitalized on unspecified dates. The patient's outcome was recovered. NOTE: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Weight decreased
Clinical narrative: This case was received on 02 February 2009 via a QScan search on the VAERS database, under reference number 332168. A 24-year-old male patient, who was previously healthy, received ACAM2000 (lot number not reported) on 24 September 2008. On 03 October 2008, nine days post vaccination, the patient developed pleuritic and substernal chest pain (6-7 out of 10), fever, but no dyspnea. On 05 October 2008, the symptoms persisted and the patient went to a health facility. On exam, the patient was afebrile with stable vital signs and O2 saturation on room air. His temperature was 98.6, pulse 86, B/P 99/63, respirations 16. Physical exam was essentially unremarkable. His primary inoculation site was healing over as anticipated. He had some costochondral tenderness. No signs and symptoms of reduced LV function by physical exam. He received INDOCIN 50 mg, which nearly alleviated his chest pain, and he was doing well since. On 08 October 2008, the patient had new onset of chest pain which was associated with occasional mild dyspnea and dizziness, cough, night sweats, fatigue, weight loss, chronic low back pain, weakness with difficulty walking, and diffuse tenderness to palpitation over most of sternum. The impression was myopericarditis, secondary to immune response to smallpox immunization. Laboratory and diagnostic test results included the following: Serum qualitative Troponin I was positive; Serum CKMB 27 (just above intermediate range upper limit of normal); essentially normal electrolytes and BUN/Cr; EKG: normal sinus rhythm and one to two millimeter ST segment elevations in II, III. The patient was reported to have been hospitalized on unspecified dates. The patient's outcome was recovered. NOTE: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 38.0
Sex: M
Vaccine: FLUN3, SMALL
Symptoms: Dermatitis acneiform, Rash erythematous, Rash pustular
Clinical narrative: This case was received on 17 December 2008 via a QScan search on the VAERS database, under reference number 328459.  A 38-year-old male patient, whose medical history was not reported, received the following vaccinations on 25 September 2008:  ACAM2000 (lot number not reported) and FLUMIST (MedImmune Vaccines, lot number not reported).  On 04 October 2008, nine days post-vaccination, the patient had "a 10 cm area of redness around area of the head, arms, back, chest, and legs with eruption of acneiform pustules".  Corrective treatment and the patient's outcome were not reported.
Age: 29.0
Sex: M
Vaccine: FLUN3, SMALL
Symptoms: Latex allergy, Pharyngeal oedema, Urticaria
Clinical narrative: This case was received on 17 December 2008 via a QScan search on the VAERS database, under reference number 328597. A 29 year-old male patient received the following vaccinations on 02 October 2008: SMALLPOX (manufacturer unknown, lot number not reported), and FLUMIST (Medimmune, lot number not reported). Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed SMALLPOX vaccine at the time of the patient's vaccination. One to two days after vaccination, the patient developed hives on his arms, chest, stomach and armpits and throat swelling. The patient was diagnosed with an allergy to latex. He was treated with BENADRYL and antibiotics and issued allergies tags which included latex. The patient recovered. List of Documents held by Sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Culture wound, Injection site cellulitis, Injection site erythema, Injection site papule, Injection site streaking
Clinical narrative: This case was received on 11 January 2009 via a QScan search on the VAERS database, under reference number 329234. A 20 year old male patient received SMALLPOX vaccine (manufacturer unknown, lot number not reported) on 30 September 2008. The patient was admitted for injection site cellulitis. The patient presented to the Emergency Department on 10 October 2008 with erythema, swelling and streaking at the site of vaccination. Symptoms began 4 days prior. The patient reported a fever beginning 2 days prior and increased pain. Papules were noted around the cellulitis area with lymphangitic streaking to the axilla. The hospital contacted the local health department which advised that the reaction was "likely a robust take and not cellulitis, and recommend to discontinue the antibiotic". Wound scraping for orthovirus was performed. No results were reported. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed SMALLPOX vaccine at the time of the patient's vaccination. List of Documents held by Sender: None. Follow-up: 3/8/2010 unable to locate - Called facility and spoke with staff in medical record. Identified the only person in the global address list with the name of interest. I emailed the individual inquiring as to his travel to this State during the time/date period of record. Several days later a reply said "wrong person".
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Injection site swelling, Lymphangitis, Pain, Pyrexia, Robust take following exposure to vaccinia virus
Clinical narrative: This case was received on 11 January 2009 via a QScan search on the VAERS database, under reference number 329234. A 20 year old male patient received SMALLPOX vaccine (manufacturer unknown, lot number not reported) on 30 September 2008. The patient was admitted for injection site cellulitis. The patient presented to the Emergency Department on 10 October 2008 with erythema, swelling and streaking at the site of vaccination. Symptoms began 4 days prior. The patient reported a fever beginning 2 days prior and increased pain. Papules were noted around the cellulitis area with lymphangitic streaking to the axilla. The hospital contacted the local health department which advised that the reaction was "likely a robust take and not cellulitis, and recommend to discontinue the antibiotic". Wound scraping for orthovirus was performed. No results were reported. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed SMALLPOX vaccine at the time of the patient's vaccination. List of Documents held by Sender: None. Follow-up: 3/8/2010 unable to locate - Called facility and spoke with staff in medical record. Identified the only person in the global address list with the name of interest. I emailed the individual inquiring as to his travel to this State during the time/date period of record. Several days later a reply said "wrong person".
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL
Symptoms: Post vaccination autoinoculation
Clinical narrative: This case was received on 11 January 2008 via a search on the VAERS database, under reference number 329239. A 24 year-old male patient received the following vaccination on 03 October 2008: smallpox (manufacturer unknown, lot number not reported), and BIOTHRAX, manufacturer and lot number not reported. Seventeen days after vaccination, on 20 October 2008, the patient experienced inadvertent inoculation of the right wrist. No additional information was reported. The patient recovered. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of Documents held by Sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL
Symptoms: Chest pain, Dyspnoea, Electrocardiogram abnormal, Pericarditis
Clinical narrative: This case was received on 11 January 2009 via a search on the VAERS database, under reference number 329397. A 29 year-old male patient received smallpox vaccine (manufacturer unknown, lot number not reported) on 05 October 2008. Five days after vaccination, on 10 October 2008, the patient was admitted to the hospital with a diagnosis of pericarditis. The patient reported experiencing shortness of breath and chest pain. He presented to the Emergency Room and was admitted overnight on telemetry. An electrocardiogram performed was reported as "abnormal". The patient was discharged the following day with orders to report back to the Cardiology Clinic on 28 October 2008 for follow-up. There may be a discrepancy between the event date and onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of Documents held by Sender: None.
Age: 28.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Chest discomfort, Chest pain, Chills, Confusional state, Dyspnoea
Clinical narrative: This case was received on 11 January 2009 via a search of the VAERS database (VAERS identification number 329622). It was originally reported to VAERS by a unknown manufacturer. A 28 year-old male patient received the following vaccination on 16 September 2008: a percutaneous injection of smallpox (trade name and manufacturer name unknown, lot number and site of administration not provided), an intramuscular injection of TYPHIM VI (lot number and site of administration not provided) and a subcutaneous injection of Anthrax (Biothrax, manufacturer Wyeth, lot number and site of administration not provided). Approximately nine hours post-vaccination, the patient reported fever, chills, periods of confusion, chest pain that was a seven on a scale of 10 with 10 being the worst pain, chest pressure with respiration and leaning forward, possible diaphoresis, nausea, frontal headache that was behind the eyes, neck pain, dyspnea, diffuse pain and a rash. The patient stated he never had a headache like that before. On 01 December 2008 the patient's medical records were received by VAERS that revealed the patient presented to the hospital on 28 September which was three days after onset of his symptoms and he was admitted. Troponin levels were elevated at 0.1 and there were T-wave changes. Diagnostic tests, other laboratory data, or treatments received were not provided. The patient was diagnosed with myopericarditis, viral syndrome, elevated troponin and T-wave changes. The discharge date from the hospital was not provided. The patient was seen in the clinic of follow-up on 30 September 2008. At the time of this report, the patient had recovered; however a recovery date was not provided. Documents held by sender: None. A corrective version was created to amend the product to ACAM2000. Although the smallpox vaccine manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 28.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Electrocardiogram T wave inversion, Headache, Myopericarditis, Nausea, Neck pain
Clinical narrative: This case was received on 11 January 2009 via a search of the VAERS database (VAERS identification number 329622). It was originally reported to VAERS by a unknown manufacturer. A 28 year-old male patient received the following vaccination on 16 September 2008: a percutaneous injection of smallpox (trade name and manufacturer name unknown, lot number and site of administration not provided), an intramuscular injection of TYPHIM VI (lot number and site of administration not provided) and a subcutaneous injection of Anthrax (Biothrax, manufacturer Wyeth, lot number and site of administration not provided). Approximately nine hours post-vaccination, the patient reported fever, chills, periods of confusion, chest pain that was a seven on a scale of 10 with 10 being the worst pain, chest pressure with respiration and leaning forward, possible diaphoresis, nausea, frontal headache that was behind the eyes, neck pain, dyspnea, diffuse pain and a rash. The patient stated he never had a headache like that before. On 01 December 2008 the patient's medical records were received by VAERS that revealed the patient presented to the hospital on 28 September which was three days after onset of his symptoms and he was admitted. Troponin levels were elevated at 0.1 and there were T-wave changes. Diagnostic tests, other laboratory data, or treatments received were not provided. The patient was diagnosed with myopericarditis, viral syndrome, elevated troponin and T-wave changes. The discharge date from the hospital was not provided. The patient was seen in the clinic of follow-up on 30 September 2008. At the time of this report, the patient had recovered; however a recovery date was not provided. Documents held by sender: None. A corrective version was created to amend the product to ACAM2000. Although the smallpox vaccine manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 28.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Pain, Pyrexia, Rash, Troponin increased, Viral infection
Clinical narrative: This case was received on 11 January 2009 via a search of the VAERS database (VAERS identification number 329622). It was originally reported to VAERS by a unknown manufacturer. A 28 year-old male patient received the following vaccination on 16 September 2008: a percutaneous injection of smallpox (trade name and manufacturer name unknown, lot number and site of administration not provided), an intramuscular injection of TYPHIM VI (lot number and site of administration not provided) and a subcutaneous injection of Anthrax (Biothrax, manufacturer Wyeth, lot number and site of administration not provided). Approximately nine hours post-vaccination, the patient reported fever, chills, periods of confusion, chest pain that was a seven on a scale of 10 with 10 being the worst pain, chest pressure with respiration and leaning forward, possible diaphoresis, nausea, frontal headache that was behind the eyes, neck pain, dyspnea, diffuse pain and a rash. The patient stated he never had a headache like that before. On 01 December 2008 the patient's medical records were received by VAERS that revealed the patient presented to the hospital on 28 September which was three days after onset of his symptoms and he was admitted. Troponin levels were elevated at 0.1 and there were T-wave changes. Diagnostic tests, other laboratory data, or treatments received were not provided. The patient was diagnosed with myopericarditis, viral syndrome, elevated troponin and T-wave changes. The discharge date from the hospital was not provided. The patient was seen in the clinic of follow-up on 30 September 2008. At the time of this report, the patient had recovered; however a recovery date was not provided. Documents held by sender: None. A corrective version was created to amend the product to ACAM2000. Although the smallpox vaccine manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 22.0
Sex: M
Vaccine: SMALL
Symptoms: Injection site erythema, Injection site pruritus, Pruritus, Rash
Clinical narrative: This case was received on 17 December 2008 via a Qscan search on the VAERS database, under reference number 330135. A 22 year-old-male patient received the following vaccination on 15 October 2008: ACAM2000 (Sanofi Pasteur Biologics Co., lot number reported). Approximately one week after vaccination, it was reported that the area around the vaccination site was red, itchy and spread to neck, arms and leg. Not all areas where the rash was present were itchy per the report. No treatment was given for this adverse event. List of documents held by sender: None
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Activated partial thromboplastin time normal, Anion gap normal, Blister, Blood albumin normal, Blood alkaline phosphatase normal
Clinical narrative: This case was received on 11 January 2009 via a QScan search on the VAERS database, under reference number 330422.  A 24 year-old male patient received the following vaccination on 25 September 2008:  SMALLPOX (manufacturer unknown, lot number not reported).  The patient was hospitalized (dates not reported) for papular vesicular lesions with blisters on his face, torso, lower legs and ankles.  He was treated with VANCOMYCIN, BENADRYL, EPIPEN, ZANTAC, LOVENOX, HYDROXYZINE, DOXEPIN, CALAMINE, refresh celluvisc GREEN, TYLENOL, MOTRIN and EUCERIN.  NOTE:  Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed SMALLPOX vaccine at the time of the patient's vaccination.  List of Documents held by Sender:  None
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Blood calcium normal, Blood chloride normal, Blood creatinine normal, Blood glucose normal, Blood immunoglobulin E normal
Clinical narrative: This case was received on 11 January 2009 via a QScan search on the VAERS database, under reference number 330422.  A 24 year-old male patient received the following vaccination on 25 September 2008:  SMALLPOX (manufacturer unknown, lot number not reported).  The patient was hospitalized (dates not reported) for papular vesicular lesions with blisters on his face, torso, lower legs and ankles.  He was treated with VANCOMYCIN, BENADRYL, EPIPEN, ZANTAC, LOVENOX, HYDROXYZINE, DOXEPIN, CALAMINE, refresh celluvisc GREEN, TYLENOL, MOTRIN and EUCERIN.  NOTE:  Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed SMALLPOX vaccine at the time of the patient's vaccination.  List of Documents held by Sender:  None
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Blood immunoglobulin G normal, Blood immunoglobulin M normal, Blood magnesium normal, Blood phosphorus normal, Blood potassium normal
Clinical narrative: This case was received on 11 January 2009 via a QScan search on the VAERS database, under reference number 330422.  A 24 year-old male patient received the following vaccination on 25 September 2008:  SMALLPOX (manufacturer unknown, lot number not reported).  The patient was hospitalized (dates not reported) for papular vesicular lesions with blisters on his face, torso, lower legs and ankles.  He was treated with VANCOMYCIN, BENADRYL, EPIPEN, ZANTAC, LOVENOX, HYDROXYZINE, DOXEPIN, CALAMINE, refresh celluvisc GREEN, TYLENOL, MOTRIN and EUCERIN.  NOTE:  Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed SMALLPOX vaccine at the time of the patient's vaccination.  List of Documents held by Sender:  None
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Blood sodium normal, Rash papular, Rash vesicular, Skin lesion
Clinical narrative: This case was received on 11 January 2009 via a QScan search on the VAERS database, under reference number 330422.  A 24 year-old male patient received the following vaccination on 25 September 2008:  SMALLPOX (manufacturer unknown, lot number not reported).  The patient was hospitalized (dates not reported) for papular vesicular lesions with blisters on his face, torso, lower legs and ankles.  He was treated with VANCOMYCIN, BENADRYL, EPIPEN, ZANTAC, LOVENOX, HYDROXYZINE, DOXEPIN, CALAMINE, refresh celluvisc GREEN, TYLENOL, MOTRIN and EUCERIN.  NOTE:  Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed SMALLPOX vaccine at the time of the patient's vaccination.  List of Documents held by Sender:  None
Age: 21.0
Sex: M
Vaccine: SMALL
Symptoms: Blood creatine phosphokinase normal, C-reactive protein normal, Cardiac enzymes increased, Chest X-ray normal, Chest discomfort
Clinical narrative: This case was received on 11 January 2009 via a search on the VAERS database, under reference number 330983. A 21 year old male patient received smallpox vaccine (manufacturer unknown, lot number not reported) on 15 August 2008. Ten days after vaccination, the patient was hospitalized with a diagnosis of acute myopericarditis. The patient presented to the Emergency Room with a two day history of sharp, mid-sternal chest pain, radiating to his neck and shoulders, which worsened by positional change and deep breathing. The patient's smallpox vaccination site progressed normally with no increase in pain or induration. There was no history of cough, shortness of breath, immobility, leg pain or swelling, trauma, sick contacts or foreign travel. The patient was treated with anti-inflammatories and was stable throughout the hospitalization without systemic symptoms. The following tests were performed and reported as normal: chest X-Ray, echocardiogram, CMP and CBC, C-reactive protein, fibrin D dimer, creatine phosphokinase, cardiac enzymes were reported as increased. An electrocardiogram was reported as "sinus rhythm with a normal axis and intervals; mild ST depression inferiorly, with ST elevation in I, aVL, and V1-4, vs. normal ECG with early repolarization". The patient was discharged two days later and referred for cardiac follow-up. He continued to have chest tightness with exercise but was asymptomatic at rest. The chest tightness gradually resolved completely. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of Documents held by Sender: None.
Age: 21.0
Sex: M
Vaccine: SMALL
Symptoms: Chest pain, Echocardiogram normal, Electrocardiogram abnormal, Fibrin D dimer normal, Full blood count normal
Clinical narrative: This case was received on 11 January 2009 via a search on the VAERS database, under reference number 330983. A 21 year old male patient received smallpox vaccine (manufacturer unknown, lot number not reported) on 15 August 2008. Ten days after vaccination, the patient was hospitalized with a diagnosis of acute myopericarditis. The patient presented to the Emergency Room with a two day history of sharp, mid-sternal chest pain, radiating to his neck and shoulders, which worsened by positional change and deep breathing. The patient's smallpox vaccination site progressed normally with no increase in pain or induration. There was no history of cough, shortness of breath, immobility, leg pain or swelling, trauma, sick contacts or foreign travel. The patient was treated with anti-inflammatories and was stable throughout the hospitalization without systemic symptoms. The following tests were performed and reported as normal: chest X-Ray, echocardiogram, CMP and CBC, C-reactive protein, fibrin D dimer, creatine phosphokinase, cardiac enzymes were reported as increased. An electrocardiogram was reported as "sinus rhythm with a normal axis and intervals; mild ST depression inferiorly, with ST elevation in I, aVL, and V1-4, vs. normal ECG with early repolarization". The patient was discharged two days later and referred for cardiac follow-up. He continued to have chest tightness with exercise but was asymptomatic at rest. The chest tightness gradually resolved completely. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of Documents held by Sender: None.
Age: 21.0
Sex: M
Vaccine: SMALL
Symptoms: Metabolic function test, Musculoskeletal pain, Myopericarditis, Neck pain
Clinical narrative: This case was received on 11 January 2009 via a search on the VAERS database, under reference number 330983. A 21 year old male patient received smallpox vaccine (manufacturer unknown, lot number not reported) on 15 August 2008. Ten days after vaccination, the patient was hospitalized with a diagnosis of acute myopericarditis. The patient presented to the Emergency Room with a two day history of sharp, mid-sternal chest pain, radiating to his neck and shoulders, which worsened by positional change and deep breathing. The patient's smallpox vaccination site progressed normally with no increase in pain or induration. There was no history of cough, shortness of breath, immobility, leg pain or swelling, trauma, sick contacts or foreign travel. The patient was treated with anti-inflammatories and was stable throughout the hospitalization without systemic symptoms. The following tests were performed and reported as normal: chest X-Ray, echocardiogram, CMP and CBC, C-reactive protein, fibrin D dimer, creatine phosphokinase, cardiac enzymes were reported as increased. An electrocardiogram was reported as "sinus rhythm with a normal axis and intervals; mild ST depression inferiorly, with ST elevation in I, aVL, and V1-4, vs. normal ECG with early repolarization". The patient was discharged two days later and referred for cardiac follow-up. He continued to have chest tightness with exercise but was asymptomatic at rest. The chest tightness gradually resolved completely. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of Documents held by Sender: None.
Age: 21.0
Sex: F
Vaccine: SMALL
Symptoms: Abortion induced, Drug exposure during pregnancy
Clinical narrative: This case was received on 02 February 2009 via a search on the VAERS database, under reference number 333276. A 21 year old female patient received the following vaccination on 22 September 2008: SMALLPOX (manufacturer unknown, lot number not reported). The patient was vaccinated during pregnancy and elected to terminate the pregnancy. No additional information was reported. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed SMALLPOX vaccine at the time of the patient's vaccination. List of Documents held by Sender: None.
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Injection site scab
Clinical narrative: This case was received on 02 February 2009 via a QScan search on the VAERS database, under reference number 331925. A 19-year0old male patient, whose medical history was not reported, received ACAM2000 (lot number not reported) on 09 June 2008. After an unspecified amount of time, the scabbed area spread to 70% of the patient's right upper arm. The patient had been advised by a corpsman to put lotion on the area. On 15 August 2008, 67 days post-vaccination, the patient went to a clinic to have the area checked. According to the reporter, the patient will likely have permanent scarring to the greater portion of his upper arm. Corrective treatment was not reported. The patient's outcome was reported as recovered.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Anorexia, Asthenia, Bundle branch block, Chest X-ray normal, Chest pain
Clinical narrative: This case was received on 02 February 2009 via a search on the VAERS database, under reference number 332863. A 20-year-old male patient, whose medical history was not reported, received ACAM2000 (lot number not reported) on 19 May 2008. On an unspecified date, the patient had elevated ST's on EKG. He had mild chest pain four weeks post immunization. He had recurrent pain "NDV/CE" when he tried to run. The patient was reported to have been hospitalized, 167 days post-vaccination, from 11 to 12 November 2008. The hospital records revealed that the final diagnosis was probable post-vaccinal smallpox immunization myopericarditis; atypical chest pain secondary to #1; possible GERD. The patient had experienced retrosternal chest pain while running with radiation to the left shoulder and slight dizziness. The pain had resolved with rest. The patient had reported that he'd had similar chest pain in the past. He became fatigued with insomnia, generally weak, dyspneic, increased thirst, nasal stuffiness, anorexia, heartburn. He was admitted to ICU for monitoring. He received treatment with NSAIDs and antacids. He responded well and was discharged to be medevaced stateside for recovery. Laboratory and diagnostic test results included the following: EKG on 12 November 2008, increased ST-s; Echo treadmill, normal limits; Chest x-ray normal; ECG: incomplete right bundle branch block, nonspecific ST-T changes; Treadmill ECG abnormal with diffuse ST segment or J-joint elevations and inverted T-waves. The patient's outcome was reported as recovered. NOTE: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Dizziness, Dyspepsia, Dyspnoea, Echocardiogram normal, Electrocardiogram ST segment elevation
Clinical narrative: This case was received on 02 February 2009 via a search on the VAERS database, under reference number 332863. A 20-year-old male patient, whose medical history was not reported, received ACAM2000 (lot number not reported) on 19 May 2008. On an unspecified date, the patient had elevated ST's on EKG. He had mild chest pain four weeks post immunization. He had recurrent pain "NDV/CE" when he tried to run. The patient was reported to have been hospitalized, 167 days post-vaccination, from 11 to 12 November 2008. The hospital records revealed that the final diagnosis was probable post-vaccinal smallpox immunization myopericarditis; atypical chest pain secondary to #1; possible GERD. The patient had experienced retrosternal chest pain while running with radiation to the left shoulder and slight dizziness. The pain had resolved with rest. The patient had reported that he'd had similar chest pain in the past. He became fatigued with insomnia, generally weak, dyspneic, increased thirst, nasal stuffiness, anorexia, heartburn. He was admitted to ICU for monitoring. He received treatment with NSAIDs and antacids. He responded well and was discharged to be medevaced stateside for recovery. Laboratory and diagnostic test results included the following: EKG on 12 November 2008, increased ST-s; Echo treadmill, normal limits; Chest x-ray normal; ECG: incomplete right bundle branch block, nonspecific ST-T changes; Treadmill ECG abnormal with diffuse ST segment or J-joint elevations and inverted T-waves. The patient's outcome was reported as recovered. NOTE: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Electrocardiogram ST-T change, Electrocardiogram T wave inversion, Electrocardiogram abnormal, Exercise electrocardiogram, Fatigue
Clinical narrative: This case was received on 02 February 2009 via a search on the VAERS database, under reference number 332863. A 20-year-old male patient, whose medical history was not reported, received ACAM2000 (lot number not reported) on 19 May 2008. On an unspecified date, the patient had elevated ST's on EKG. He had mild chest pain four weeks post immunization. He had recurrent pain "NDV/CE" when he tried to run. The patient was reported to have been hospitalized, 167 days post-vaccination, from 11 to 12 November 2008. The hospital records revealed that the final diagnosis was probable post-vaccinal smallpox immunization myopericarditis; atypical chest pain secondary to #1; possible GERD. The patient had experienced retrosternal chest pain while running with radiation to the left shoulder and slight dizziness. The pain had resolved with rest. The patient had reported that he'd had similar chest pain in the past. He became fatigued with insomnia, generally weak, dyspneic, increased thirst, nasal stuffiness, anorexia, heartburn. He was admitted to ICU for monitoring. He received treatment with NSAIDs and antacids. He responded well and was discharged to be medevaced stateside for recovery. Laboratory and diagnostic test results included the following: EKG on 12 November 2008, increased ST-s; Echo treadmill, normal limits; Chest x-ray normal; ECG: incomplete right bundle branch block, nonspecific ST-T changes; Treadmill ECG abnormal with diffuse ST segment or J-joint elevations and inverted T-waves. The patient's outcome was reported as recovered. NOTE: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Insomnia, Intensive care, Musculoskeletal pain, Myopericarditis, Nasal congestion
Clinical narrative: This case was received on 02 February 2009 via a search on the VAERS database, under reference number 332863. A 20-year-old male patient, whose medical history was not reported, received ACAM2000 (lot number not reported) on 19 May 2008. On an unspecified date, the patient had elevated ST's on EKG. He had mild chest pain four weeks post immunization. He had recurrent pain "NDV/CE" when he tried to run. The patient was reported to have been hospitalized, 167 days post-vaccination, from 11 to 12 November 2008. The hospital records revealed that the final diagnosis was probable post-vaccinal smallpox immunization myopericarditis; atypical chest pain secondary to #1; possible GERD. The patient had experienced retrosternal chest pain while running with radiation to the left shoulder and slight dizziness. The pain had resolved with rest. The patient had reported that he'd had similar chest pain in the past. He became fatigued with insomnia, generally weak, dyspneic, increased thirst, nasal stuffiness, anorexia, heartburn. He was admitted to ICU for monitoring. He received treatment with NSAIDs and antacids. He responded well and was discharged to be medevaced stateside for recovery. Laboratory and diagnostic test results included the following: EKG on 12 November 2008, increased ST-s; Echo treadmill, normal limits; Chest x-ray normal; ECG: incomplete right bundle branch block, nonspecific ST-T changes; Treadmill ECG abnormal with diffuse ST segment or J-joint elevations and inverted T-waves. The patient's outcome was reported as recovered. NOTE: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Pain, Thirst, Vaccination complication
Clinical narrative: This case was received on 02 February 2009 via a search on the VAERS database, under reference number 332863. A 20-year-old male patient, whose medical history was not reported, received ACAM2000 (lot number not reported) on 19 May 2008. On an unspecified date, the patient had elevated ST's on EKG. He had mild chest pain four weeks post immunization. He had recurrent pain "NDV/CE" when he tried to run. The patient was reported to have been hospitalized, 167 days post-vaccination, from 11 to 12 November 2008. The hospital records revealed that the final diagnosis was probable post-vaccinal smallpox immunization myopericarditis; atypical chest pain secondary to #1; possible GERD. The patient had experienced retrosternal chest pain while running with radiation to the left shoulder and slight dizziness. The pain had resolved with rest. The patient had reported that he'd had similar chest pain in the past. He became fatigued with insomnia, generally weak, dyspneic, increased thirst, nasal stuffiness, anorexia, heartburn. He was admitted to ICU for monitoring. He received treatment with NSAIDs and antacids. He responded well and was discharged to be medevaced stateside for recovery. Laboratory and diagnostic test results included the following: EKG on 12 November 2008, increased ST-s; Echo treadmill, normal limits; Chest x-ray normal; ECG: incomplete right bundle branch block, nonspecific ST-T changes; Treadmill ECG abnormal with diffuse ST segment or J-joint elevations and inverted T-waves. The patient's outcome was reported as recovered. NOTE: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency has been calculated using the event date.
Age: 25.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Back pain, Body temperature increased, CSF glucose decreased, CSF lymphocyte count increased, CSF monocyte count increased
Clinical narrative: This case was received on 02 February 2009 via a search of the VAERS database (333211). It was originally reported to VAERS by an unknown manufacturer. A 25-year-old male patient received the following vaccinations on 13 November 2008: a percutaneous injection of ACAM2000 (lot not reported), an injection (route unknown) of TYPHIM VI (lot not reported), and an injection (route unknown) of BIOTHRAX (lot not reported manufacturer by Bioport Corporation). The reported symptoms began 17 November 2008, four days post-vaccination. On 18 November 2008, the patient was seen in military sick call and subsequently sent to the hospital for neck stiffness/discomfort, a temperature of 101 degrees Fahrenheit, body aches in his legs and lower back, nausea, and vomiting. The patient presented to the hospital with a two day history of headache, nausea, photophobia and intractable vomiting/nausea. He was febrile and laboratory test results showed CSF protein 118, glucose 49, mononuclear cells 92% with 82% lymph and 10 mono histiocytes, and CSF WBC 414. A gram stain showed many white blood cells and no organisms. A chest x-ray and CT of the head were negative. According to the reporter, medical records from dates of services 18 November - 21 November 2008 listed discharge diagnosis of viral meningitis, probably secondary to ACAM2000. The patient recovered from the event (date of recovery not reported) and no additional information was provided. Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: CSF mononuclear cell count increased, CSF protein increased, CSF white blood cell count increased, Chest X-ray normal, Computerised tomogram normal
Clinical narrative: This case was received on 02 February 2009 via a search of the VAERS database (333211). It was originally reported to VAERS by an unknown manufacturer. A 25-year-old male patient received the following vaccinations on 13 November 2008: a percutaneous injection of ACAM2000 (lot not reported), an injection (route unknown) of TYPHIM VI (lot not reported), and an injection (route unknown) of BIOTHRAX (lot not reported manufacturer by Bioport Corporation). The reported symptoms began 17 November 2008, four days post-vaccination. On 18 November 2008, the patient was seen in military sick call and subsequently sent to the hospital for neck stiffness/discomfort, a temperature of 101 degrees Fahrenheit, body aches in his legs and lower back, nausea, and vomiting. The patient presented to the hospital with a two day history of headache, nausea, photophobia and intractable vomiting/nausea. He was febrile and laboratory test results showed CSF protein 118, glucose 49, mononuclear cells 92% with 82% lymph and 10 mono histiocytes, and CSF WBC 414. A gram stain showed many white blood cells and no organisms. A chest x-ray and CT of the head were negative. According to the reporter, medical records from dates of services 18 November - 21 November 2008 listed discharge diagnosis of viral meningitis, probably secondary to ACAM2000. The patient recovered from the event (date of recovery not reported) and no additional information was provided. Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Gram stain negative, Headache, Meningitis viral, Musculoskeletal discomfort, Musculoskeletal stiffness
Clinical narrative: This case was received on 02 February 2009 via a search of the VAERS database (333211). It was originally reported to VAERS by an unknown manufacturer. A 25-year-old male patient received the following vaccinations on 13 November 2008: a percutaneous injection of ACAM2000 (lot not reported), an injection (route unknown) of TYPHIM VI (lot not reported), and an injection (route unknown) of BIOTHRAX (lot not reported manufacturer by Bioport Corporation). The reported symptoms began 17 November 2008, four days post-vaccination. On 18 November 2008, the patient was seen in military sick call and subsequently sent to the hospital for neck stiffness/discomfort, a temperature of 101 degrees Fahrenheit, body aches in his legs and lower back, nausea, and vomiting. The patient presented to the hospital with a two day history of headache, nausea, photophobia and intractable vomiting/nausea. He was febrile and laboratory test results showed CSF protein 118, glucose 49, mononuclear cells 92% with 82% lymph and 10 mono histiocytes, and CSF WBC 414. A gram stain showed many white blood cells and no organisms. A chest x-ray and CT of the head were negative. According to the reporter, medical records from dates of services 18 November - 21 November 2008 listed discharge diagnosis of viral meningitis, probably secondary to ACAM2000. The patient recovered from the event (date of recovery not reported) and no additional information was provided. Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Nausea, Pain in extremity, Photophobia, Vomiting
Clinical narrative: This case was received on 02 February 2009 via a search of the VAERS database (333211). It was originally reported to VAERS by an unknown manufacturer. A 25-year-old male patient received the following vaccinations on 13 November 2008: a percutaneous injection of ACAM2000 (lot not reported), an injection (route unknown) of TYPHIM VI (lot not reported), and an injection (route unknown) of BIOTHRAX (lot not reported manufacturer by Bioport Corporation). The reported symptoms began 17 November 2008, four days post-vaccination. On 18 November 2008, the patient was seen in military sick call and subsequently sent to the hospital for neck stiffness/discomfort, a temperature of 101 degrees Fahrenheit, body aches in his legs and lower back, nausea, and vomiting. The patient presented to the hospital with a two day history of headache, nausea, photophobia and intractable vomiting/nausea. He was febrile and laboratory test results showed CSF protein 118, glucose 49, mononuclear cells 92% with 82% lymph and 10 mono histiocytes, and CSF WBC 414. A gram stain showed many white blood cells and no organisms. A chest x-ray and CT of the head were negative. According to the reporter, medical records from dates of services 18 November - 21 November 2008 listed discharge diagnosis of viral meningitis, probably secondary to ACAM2000. The patient recovered from the event (date of recovery not reported) and no additional information was provided. Documents held by sender: None.